William Strohl, former vice president of biologics research at the BCoE, was promoted to head of Janssen's biotech-focused drug development group. His previous role was filled by Robert Friesen, who came from J&J's Crucell Vaccine Institute. Barry…
written on 17.06.2014
BioNotebook: Janssen hunts for biologics; Aduro, Celsion/EGEN, Agios/Celgene and Aeterna Zentaris